• bioAffinity Technologies closed a $3.2 million public offering of common stock.
• Issued 4,000,000 shares, or pre-funded warrants in lieu, priced at $0.80 per share or $0.793 per pre-funded warrant.
• Pre-funded warrants are immediately exercisable for one share, expiring only when fully exercised.
• WallachBeth Capital served as sole placement agent.
• Closing expected on or about June 18, 2026, subject to customary closing conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. bioAffinity Technologies Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260618108310) on June 18, 2026, and is solely responsible for the information contained therein.